Acorda Therapeutics (30)
Browse by Contract Category
Contracts
-
Employment letter agreement, dated June 2, 2022, by and between the Registrant and Neil S. Belloff
(Filed With SEC on August 9, 2022)
-
Second Amendment to Manufacturing Services Agreement dated as of December 31, 2021, by and between the Registrant and Catalent Massachusetts, LLC
(Filed With SEC on March 18, 2022)
-
Form of stock option certificate under the Acorda Therapeutics 2016 Inducement Plan
(Filed With SEC on March 18, 2022)
-
Acorda Therapeutics 2016 Inducement Plan
(Filed With SEC on March 18, 2022)
-
Employment letter agreement, dated June 2, 2022, by and between the Registrant and Michael Gesser
(Filed With SEC on August 9, 2022)
-
Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Kerry Clem
(Filed With SEC on August 9, 2022)
-
Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Lauren Sabella
(Filed With SEC on August 9, 2022)
-
First Amendment to Manufacturing Services Agreement dated as of October 28, 2021, by and between the Registrant and Catalent Massachusetts, LLC
(Filed With SEC on March 18, 2022)
-
Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff
(Filed With SEC on March 18, 2022)
-
Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser
(Filed With SEC on March 18, 2022)
-
Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D
(Filed With SEC on March 18, 2022)
-
Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D
(Filed With SEC on March 18, 2022)
-
Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella
(Filed With SEC on March 18, 2022)
-
Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem
(Filed With SEC on September 9, 2021)
-
Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021
(Filed With SEC on May 12, 2021)
-
Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer
(Filed With SEC on May 12, 2021)
-
Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan
(Filed With SEC on May 12, 2021)
-
Manufacturing Services Agreement, dated February 10, 2021, between the Registrant and Catalent Massachusetts LLC
(Filed With SEC on March 16, 2021)
-
Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc
(Filed With SEC on March 16, 2021)
-
Description of Common Stock
(Filed With SEC on March 16, 2021)
-
Specimen stock certificate evidencing shares of common stock
(Filed With SEC on March 16, 2021)
-
At The Market Offering Agreement, dated January 13, 2021, between Acorda Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on January 13, 2021)
-
Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman
(Filed With SEC on February 28, 2020)
-
Description of Common Stock
(Filed With SEC on February 28, 2020)
-
Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent
(Filed With SEC on December 26, 2019)
-
Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto
(Filed With SEC on December 26, 2019)
-
Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent
(Filed With SEC on December 26, 2019)
-
Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein
(Filed With SEC on December 26, 2019)
-
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman
(Filed With SEC on November 7, 2019)
-
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence
(Filed With SEC on November 7, 2019)